Duchenne muscular dystrophy
Information
- Disease name
- Duchenne muscular dystrophy
- Disease ID
- DOID:11723
- Description
- "A muscular dystrophy that has_material_basis_in X-linked mutations in the DMD gene found on the X chromosome. It is characterized by rapidly progressing muscle weakness and muscle atrophy initially involving the lower extremities and eventually affecting the whole body. It affects males whereas females can be carriers. The symptoms start before the age of six and may appear at infancy." [url:http\://en.wikipedia.org/wiki/Duchenne_muscular_dystrophy, url:http\://omim.org/entry/300377, url:http\://www.genome.gov/19518854]
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| DMD | X | 31,119,222 | 33,211,549 | 34 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05938023 | Active, not recruiting | Phase 2 | A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy | May 18, 2023 | March 5, 2025 |
| NCT06241950 | Active, not recruiting | Phase 1 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74) | January 29, 2024 | September 30, 2026 |
| NCT04433234 | Active, not recruiting | Phase 2 | Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy | June 30, 2020 | January 31, 2027 |
| NCT04428476 | Active, not recruiting | Phase 2 | Open-label Extension of the HOPE-2 Trial | July 20, 2020 | March 2025 |
| NCT04004065 | Active, not recruiting | Phase 2 | Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment | June 26, 2019 | January 31, 2029 |
| NCT01633866 | Active, not recruiting | Pediatric Radio Frequency Coils Generic | July 2012 | June 2025 | |
| NCT05661071 | Active, not recruiting | Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions | May 11, 2022 | March 1, 2023 | |
| NCT05514249 | Active, not recruiting | Phase 1 | Treatment of a Single Patient With CRD-TMH-001 | August 31, 2022 | September 2023 |
| NCT03936894 | Active, not recruiting | Phase 1/Phase 2 | Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy | May 1, 2019 | April 2024 |
| NCT04687020 | Active, not recruiting | Phase 4 | Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502) | June 10, 2021 | October 2032 |
| NCT04906460 | Active, not recruiting | Phase 1/Phase 2 | Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53) | September 28, 2021 | May 2025 |
| NCT03368742 | Active, not recruiting | Phase 1/Phase 2 | Microdystrophin Gene Transfer Study in Adolescents and Children With DMD | December 6, 2017 | December 2027 |
| NCT03362502 | Active, not recruiting | Phase 1 | A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy | January 23, 2018 | March 30, 2026 |
| NCT03333590 | Active, not recruiting | Phase 1/Phase 2 | Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy | November 6, 2017 | October 2023 |
| NCT04281485 | Active, not recruiting | Phase 3 | Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy | November 5, 2020 | April 19, 2029 |
| NCT05185622 | Active, not recruiting | Phase 2 | A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD) | March 21, 2022 | July 2024 |
| NCT04768062 | Active, not recruiting | Phase 3 | Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X) | April 13, 2021 | November 2025 |
| NCT06274983 | Active, not recruiting | N/A | DMD- Interactive Virtual Reality Study | April 20, 2023 | February 29, 2024 |
| NCT02500381 | Active, not recruiting | Phase 3 | Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) | September 28, 2016 | October 3, 2025 |
| NCT04240314 | Active, not recruiting | Phase 1/Phase 2 | AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. | January 15, 2020 | November 19, 2025 |
| NCT05096221 | Active, not recruiting | Phase 3 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) | October 27, 2021 | November 30, 2024 |
| NCT02592941 | Approved for marketing | Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy | |||
| NCT03863119 | Available | Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy | |||
| NCT01388764 | Completed | Phase 1 | Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids | January 2012 | May 2012 |
| NCT01396239 | Completed | Phase 2 | Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients | July 2011 | June 2012 |
| NCT01422200 | Completed | Phase 4 | Flu Vaccine Study in Neuromuscular Patients 2011 | August 2011 | May 2012 |
| NCT01491555 | Completed | Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy | April 2012 | September 2015 | |
| NCT01521546 | Completed | N/A | Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy | February 2012 | June 2016 |
| NCT01523964 | Completed | N/A | DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls | February 2012 | August 2012 |
| NCT01540604 | Completed | Phase 2 | CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers | ||
| NCT01557400 | Completed | Phase 3 | Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada | May 20, 2012 | January 19, 2018 |
| NCT01580501 | Completed | Phase 1 | PDE Inhibitors in DMD Study (Acute Dosing Study) | March 2012 | |
| NCT01603407 | Completed | Phase 3 | Finding the Optimum Regimen for Duchenne Muscular Dystrophy | January 2013 | November 2019 |
| NCT01645098 | Completed | N/A | Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy | August 2011 | June 2013 |
| NCT01648634 | Completed | Phase 3 | Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy | February 13, 2012 | July 20, 2021 |
| NCT01874275 | Completed | N/A | Duchenne Muscular Dystrophy Clinical Trial | June 2013 | September 2014 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT01954940 | Completed | N/A | Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy | March 2013 | March 2017 |
| NCT01963897 | Completed | Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life. | August 2013 | June 2017 | |
| NCT01981915 | Completed | N/A | Optimum Insufflation Capacity in NMD | January 2011 | March 2013 |
| NCT01999075 | Completed | Phase 4 | Stacking Exercises Aid the Decline in FVC and Sick Time | March 2013 | November 22, 2018 |
| NCT02034305 | Completed | Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy | January 2014 | January 1, 2021 | |
| NCT02056808 | Completed | Phase 1 | A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) | November 2013 | July 2014 |
| NCT00004646 | Completed | Phase 3 | Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy | April 1995 | |
| NCT00005574 | Completed | Phase 1 | Gentamicin Treatment of Muscular Dystrophy | February 2000 | January 2001 |
| NCT00110669 | Completed | Phase 3 | High-dose Prednisone in Duchenne Muscular Dystrophy | January 2004 | February 2008 |
| NCT00159250 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy | October 26, 2007 | March 31, 2009 |
| NCT00264888 | Completed | Phase 2 | Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy | December 2005 | May 2007 |
| NCT00312247 | Completed | Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy | April 2006 | March 2015 | |
| NCT00428935 | Completed | Phase 1 | Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy | March 2006 | July 2010 |
| NCT00451074 | Completed | Phase 1 | Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons | March 2007 | July 2009 |
| NCT00592553 | Completed | Phase 2 | Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) | February 29, 2008 | December 31, 2009 |
| NCT00758225 | Completed | Phase 2 | Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension) | September 2008 | January 2011 |
| NCT00844597 | Completed | Phase 1/Phase 2 | Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients | January 2009 | December 2010 |
| NCT00873782 | Completed | Phase 1 | Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy | March 2009 | February 2014 |
| NCT01037309 | Completed | Phase 1/Phase 2 | Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD) | December 2009 | October 2013 |
| NCT01066455 | Completed | Cardiac Outcome Measures in Children With Muscular Dystrophy | January 2010 | May 2012 | |
| NCT01081080 | Completed | Cardiac Magnetic Resonance in Children With Muscular Dystrophy | April 2010 | October 2011 | |
| NCT01098708 | Completed | This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy | March 2010 | November 2013 | |
| NCT01125709 | Completed | Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS) | January 2010 | August 2010 | |
| NCT01126697 | Completed | Phase 2/Phase 3 | Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies | February 2010 | December 2017 |
| NCT01182324 | Completed | The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor | July 30, 2010 | June 24, 2013 | |
| NCT01183767 | Completed | Phase 2/Phase 3 | Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy | December 30, 2010 | September 6, 2018 |
| NCT01207908 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy | November 2010 | June 2013 |
| NCT01335295 | Completed | Phase 1 | Safety Study of Flavocoxid in Duchenne Muscular Dystrophy | March 2011 | December 2013 |
| NCT01359670 | Completed | Early Phase 1 | Tadalafil and Sildenafil for Duchenne Muscular Dystrophy | May 2011 | May 2013 |
| NCT02081625 | Completed | Phase 1 | Exploratory Study of NS-065/NCNP-01 in DMD | June 2013 | August 2015 |
| NCT02167217 | Completed | Phase 2 | Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy | April 17, 2014 | March 22, 2017 |
| NCT02168114 | Completed | N/A | Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle | July 2014 | January 8, 2018 |
| NCT02246478 | Completed | Phase 1 | A Study of TAS-205 for Duchenne Muscular Dystrophy | September 2014 | September 2015 |
| NCT02251600 | Completed | Phase 1 | A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy | December 2014 | October 2015 |
| NCT02295748 | Completed | Phase 1 | An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort | December 2014 | August 24, 2017 |
| NCT02310906 | Completed | Phase 1/Phase 2 | Phase I/II Study of SRP-4053 in DMD Patients | January 13, 2015 | March 25, 2019 |
| NCT02340923 | Completed | A Device for Rapid, Painless, Bedside Muscle Evaluation of Children | January 2015 | August 2016 | |
| NCT02354352 | Completed | Phase 3 | Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy | March 20, 2015 | May 2018 |
| NCT02354781 | Completed | Phase 1/Phase 2 | Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy | January 2015 | November 2017 |
| NCT02376816 | Completed | Phase 1 | Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy | March 2015 | September 2017 |
| NCT02418338 | Completed | N/A | 2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children | January 2014 | June 2017 |
| NCT02421523 | Completed | N/A | Strength Training in Duchenne Muscular Dystrophy | May 30, 2015 | October 8, 2018 |
| NCT02485938 | Completed | Phase 1/Phase 2 | HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) | January 2016 | September 2017 |
| NCT02516085 | Completed | Phase 1 | Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin | January 2012 | October 2012 |
| NCT02530905 | Completed | Phase 1 | Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients | October 8, 2015 | October 3, 2018 |
| NCT02571205 | Completed | Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy | November 2015 | March 2019 | |
| NCT02667483 | Completed | Phase 1/Phase 2 | Study of DS-5141b in Patients With Duchenne Muscular Dystrophy | October 2015 | October 20, 2020 |
| NCT02740972 | Completed | Phase 2 | Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) | December 2016 | April 2018 |
| NCT02752048 | Completed | Phase 2 | A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy | May 2016 | October 17, 2017 |
| NCT02760264 | Completed | Phase 2 | A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | June 2016 | May 1, 2018 |
| NCT02760277 | Completed | Phase 2 | An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | July 28, 2016 | April 26, 2018 |
| NCT02780492 | Completed | Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study | April 11, 2012 | April 28, 2022 | |
| NCT02819557 | Completed | Phase 2 | Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy | June 9, 2016 | February 9, 2018 |
| NCT02835079 | Completed | Phase 1 | Treatment Effect of Tamoxifen on Patients With DMD | November 2016 | November 2020 |
| NCT02851797 | Completed | Phase 3 | Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy | June 6, 2017 | February 22, 2022 |
| NCT02891434 | Completed | N/A | Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy | February 2016 | December 2016 |
| NCT02964377 | Completed | Phase 1/Phase 2 | Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents | November 2016 | July 2018 |
| NCT02994030 | Completed | Biomarker for Duchenne Muscular Dystrophy | August 20, 2018 | March 11, 2022 | |
| NCT03002298 | Completed | N/A | Virtual Reality in Individuals With Duchenne Muscular Dystrophy | January 2016 | October 2016 |
| NCT03038399 | Completed | Phase 2 | Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | February 2, 2017 | April 30, 2020 |
| NCT03039686 | Completed | Phase 2/Phase 3 | Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy | July 6, 2017 | April 28, 2020 |
| NCT03167255 | Completed | Phase 2 | Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) | July 6, 2017 | November 15, 2021 |
| NCT03218995 | Completed | Phase 2 | Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping | August 16, 2017 | March 10, 2021 |
| NCT03319030 | Completed | Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD) | September 1, 2017 | September 30, 2018 | |
| NCT03354039 | Completed | Phase 3 | Tamoxifen in Duchenne Muscular Dystrophy | June 12, 2018 | October 18, 2022 |
| NCT03375164 | Completed | Phase 1/Phase 2 | A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) | January 4, 2018 | April 25, 2023 |
| NCT03439670 | Completed | Phase 2 | A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) | June 29, 2018 | August 19, 2021 |
| NCT03490214 | Completed | N/A | Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography | June 1, 2018 | September 1, 2018 |
| NCT03508947 | Completed | Phase 1 | Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy | January 24, 2018 | March 6, 2019 |
| NCT03521271 | Completed | Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy | April 5, 2017 | January 26, 2018 | |
| NCT03529240 | Completed | N/A | Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption | June 10, 2017 | October 5, 2017 |
| NCT03534349 | Completed | Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance | January 2017 | December 2017 | |
| NCT03541070 | Completed | N/A | The Effect of Kinesiology Taping on Balance in Duchenne Muscular Dystrophy | June 10, 2017 | November 10, 2017 |
| NCT03552874 | Completed | Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy | January 1, 2017 | March 31, 2018 | |
| NCT03589573 | Completed | Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy | March 24, 2017 | January 1, 2018 | |
| NCT03589612 | Completed | Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy | March 8, 2018 | January 24, 2019 | |
| NCT03648827 | Completed | Phase 2 | A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) | December 21, 2018 | October 23, 2020 |
| NCT03680365 | Completed | Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families | September 20, 2018 | March 15, 2019 | |
| NCT03760029 | Completed | N/A | A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy | July 24, 2019 | March 21, 2023 |
| NCT03786913 | Completed | Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases | March 8, 2016 | February 2, 2019 | |
| NCT03796637 | Completed | Phase 2 | A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren | April 11, 2019 | June 3, 2019 |
| NCT03947112 | Completed | Physical Activity Level of Norwegian Boys With Duchenne Muscular Dystrophy | August 20, 2020 | June 30, 2021 | |
| NCT03951675 | Completed | The Burden of Access in Duchenne Muscular Dystrophy in the US | June 18, 2019 | May 28, 2020 | |
| NCT04060199 | Completed | Phase 3 | Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53) | April 14, 2020 | October 19, 2023 |
| NCT04120168 | Completed | Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease | April 1, 2019 | October 21, 2022 | |
| NCT04129294 | Completed | Phase 1/Phase 2 | Exploratory Study of NS-089/NCNP-02 in DMD | December 2, 2019 | May 31, 2022 |
| NCT04173234 | Completed | N/A | Aerobic Exercise in Duchenne Muscular Dystrophy | April 11, 2019 | December 15, 2020 |
| NCT04179409 | Completed | Phase 2 | A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications. | February 18, 2020 | September 1, 2023 |
| NCT04193085 | Completed | Wearable Technology to Assess Gait Function in SMA and DMD | November 25, 2019 | August 31, 2023 | |
| NCT04335942 | Completed | N/A | Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor | September 30, 2021 | June 1, 2023 |
| NCT04384354 | Completed | Digestive Events in Duchenne Muscular Dystrophy Patients | January 2007 | April 2019 | |
| NCT04607824 | Completed | Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task | March 2014 | June 2020 | |
| NCT04740554 | Completed | Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy | March 1, 2013 | February 1, 2015 | |
| NCT04956289 | Completed | Phase 2 | Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53) | July 1, 2021 | July 13, 2023 |
| NCT05244395 | Completed | N/A | Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy | February 10, 2020 | February 10, 2022 |
| NCT05274555 | Completed | Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy | March 27, 2019 | June 29, 2021 | |
| NCT05281120 | Completed | N/A | Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy | November 2006 | November 2007 |
| NCT05305976 | Completed | N/A | Telerehabilitation in Duchenne Muscular Dystrophy | January 11, 2021 | January 1, 2022 |
| NCT05330195 | Completed | N/A | Bicycle Ergometer Training in Duchenne Muscular Dystrophy | April 18, 2022 | May 25, 2023 |
| NCT05338099 | Completed | Phase 1 | Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD) | January 18, 2022 | December 28, 2022 |
| NCT05436210 | Completed | Postural and Anthropometric Properties of Foot and Ankle of Patients With DMD | June 23, 2022 | November 23, 2022 | |
| NCT05464446 | Completed | Examination of Lower Urinary System Symptoms With Duchenne Muscular Dystrophy | October 1, 2021 | June 20, 2022 | |
| NCT05549999 | Completed | Cultural Adaptation, Validity, and Reliability of the Turkish Version of North Star Ambulatory Assessment | November 1, 2022 | May 25, 2023 | |
| NCT05559710 | Completed | Motor Imagery in Duchenne Muscular Dystrophy | June 20, 2022 | September 25, 2023 | |
| NCT05564962 | Completed | Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD) | January 19, 2021 | September 20, 2021 | |
| NCT05575648 | Completed | N/A | Dual Task in Duchenne Muscular Dystrophy | September 6, 2022 | May 1, 2023 |
| NCT05657938 | Completed | Evaluation of Home Based Assessments on Participants With DMD | October 13, 2022 | April 4, 2023 | |
| NCT06103006 | Completed | N/A | Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy | January 1, 2021 | February 10, 2022 |
| NCT06174025 | Completed | Validity and Reliability of the 6 Minute Pegboard Ring Test | June 30, 2023 | January 1, 2024 | |
| NCT06304064 | Completed | Phase 2 | Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) | June 21, 2018 | March 6, 2019 |
| NCT06379906 | Completed | Upper Extremity Muscle Strength, Balance and Functional Skills in DMD | November 10, 2023 | March 10, 2024 | |
| NCT06412328 | Completed | N/A | Psychoeducation Program for Parents of Children With DMD | June 21, 2023 | August 29, 2023 |
| NCT03836300 | Enrolling by invitation | N/A | Parent and Infant Inter(X)Action Intervention (PIXI) | November 30, 2018 | June 30, 2025 |
| NCT05967351 | Enrolling by invitation | Phase 3 | A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study | September 27, 2023 | November 30, 2030 |
| NCT06295718 | Enrolling by invitation | Tele-assessment of Functional Performance and Quality of Life in Patients With Duchenne Muscular Dystrophy: Validity and Reliability Study | July 1, 2023 | May 10, 2024 | |
| NCT01247207 | Enrolling by invitation | Phase 3 | Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) | November 30, 2010 | April 30, 2024 |
| NCT03373968 | Enrolling by invitation | Phase 2/Phase 3 | Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study | October 24, 2017 | December 2025 |
| NCT06244082 | Enrolling by invitation | Phase 2 | Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping | January 22, 2024 | December 31, 2026 |
| NCT03655223 | Enrolling by invitation | Early Check: Expanded Screening in Newborns | October 15, 2018 | December 31, 2025 | |
| NCT02636686 | No longer available | Extension Study of Drisapersen in DMD Subjects | |||
| NCT03433807 | No longer available | Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD) | |||
| NCT06450639 | Not yet recruiting | Phase 2 | An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy | September 30, 2024 | June 30, 2027 |
| NCT05558813 | Not yet recruiting | N/A | Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP) | November 2024 | April 2029 |
| NCT06109103 | Not yet recruiting | N/A | Telerehabilitation-based Motor Imagery Training in Children With Duchenne Muscular Dystrophy | December 15, 2023 | December 1, 2025 |
| NCT05849688 | Not yet recruiting | N/A | Bicycle Training on Ventilatory Functions in Duchenne Muscular Dystrophy | May 15, 2023 | August 15, 2023 |
| NCT06053814 | Not yet recruiting | Phase 1/Phase 2 | NS-050/NCNP-03 in Boys With DMD (Meteor50) | July 2024 | May 2027 |
| NCT05715957 | Not yet recruiting | Follow-up Study on Female Carriers With DMD Gene Variants | March 1, 2023 | August 1, 2025 | |
| NCT06290713 | Not yet recruiting | Phase 2 | Vasodilator and Exercise Study for DMD (VASO-REx) | March 2024 | November 2026 |
| NCT06363526 | Not yet recruiting | N/A | Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy. | May 5, 2024 | November 30, 2024 |
| NCT06328725 | Not yet recruiting | Phase 1/Phase 2 | Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy | March 2024 | November 2025 |
| NCT05540860 | Recruiting | Phase 2 | A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX) | October 24, 2022 | February 2026 |
| NCT06093100 | Recruiting | Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim | August 2024 | December 2030 | |
| NCT06100887 | Recruiting | Phase 2 | Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene Therapy (FOX) | March 22, 2024 | June 2025 |
| NCT01484678 | Recruiting | Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy | September 1, 2020 | August 31, 2025 | |
| NCT05689164 | Recruiting | Phase 3 | A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy. | March 13, 2023 | May 15, 2039 |
| NCT05683379 | Recruiting | AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD | December 20, 2022 | December 2024 | |
| NCT06445985 | Recruiting | N/A | Hydrotherapy in Duchenne Muscular Dystrophy (DMD) | November 2, 2022 | December 12, 2025 |
| NCT05753462 | Recruiting | Phase 1/Phase 2 | Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy | April 26, 2023 | February 2025 |
| NCT05933057 | Recruiting | Phase 3 | Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy | February 19, 2024 | February 2028 |
| NCT04529707 | Recruiting | N/A | Sleep Intervention in Young Boys With Duchenne Muscular Dystrophy | February 17, 2021 | August 31, 2026 |
| NCT04583917 | Recruiting | Brain Involvement in Dystrophinopathies Part 1 | March 30, 2021 | December 2023 | |
| NCT04587908 | Recruiting | Phase 3 | A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） | November 1, 2020 | May 2027 |
| NCT06114056 | Recruiting | Phase 1 | A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) | January 22, 2024 | December 31, 2028 |
| NCT02069756 | Recruiting | The Duchenne Registry | October 2007 | October 2047 | |
| NCT05982119 | Recruiting | N/A | Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study | July 10, 2020 | March 2026 |
| NCT05670730 | Recruiting | Phase 1/Phase 2 | Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping | November 9, 2022 | March 2025 |
| NCT04668716 | Recruiting | Brain Involvement in Dystrophinopathies Part 2 | October 11, 2021 | May 2024 | |
| NCT06366815 | Recruiting | phenotypeS in Non Ambulant Duchenne Muscular Dystrophy | August 30, 2022 | December 30, 2025 | |
| NCT05641805 | Recruiting | Physical Activity Level and Cognitive Functions in Children With Duchenne Muscular Dystrophy | November 29, 2022 | November 1, 2023 | |
| NCT06124196 | Recruiting | Wearable Technology to Evaluate Hyperglycemia and HRV in DMD | March 20, 2024 | February 2031 | |
| NCT05712447 | Recruiting | Duchenne Muscular Dystrophy Video Assessment Registry | September 1, 2022 | September 1, 2027 | |
| NCT05601986 | Recruiting | N/A | Motor Imagery on Children With DMD on Gait and Balance Functions | December 16, 2022 | December 1, 2024 |
| NCT03882827 | Recruiting | Natural History of Duchenne Muscular Dystrophy | December 19, 2019 | June 30, 2023 | |
| NCT03611244 | Recruiting | N/A | Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device | August 7, 2018 | December 2024 |
| NCT06128564 | Recruiting | Phase 2 | A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD) | November 29, 2023 | November 30, 2032 |
| NCT04972604 | Recruiting | CureDuchenne Link®: A Resource for Research | July 9, 2021 | July 9, 2031 | |
| NCT05016908 | Recruiting | Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy | November 30, 2019 | May 2024 | |
| NCT05019625 | Recruiting | Biomarker Development for Muscular Dystrophies | February 20, 2015 | June 2027 | |
| NCT05967793 | Recruiting | N/A | Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular Dystrophy | July 2023 | November 2023 |
| NCT03779646 | Recruiting | Phase 2/Phase 3 | Bisoprolol in DMD Early Cardiomyopathy | January 16, 2019 | July 1, 2024 |
| NCT05881408 | Recruiting | Phase 3 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) | May 31, 2023 | January 31, 2027 |
| NCT05195775 | Recruiting | Phase 2/Phase 3 | Tadalafil as Adjuvant Therapy for DMD | December 14, 2021 | January 20, 2025 |
| NCT05693142 | Recruiting | Phase 1/Phase 2 | AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) | January 4, 2023 | December 2025 |
| NCT04012671 | Recruiting | A Registered Cohort Study on Duchenne Muscular Dystrophy | July 1, 2019 | December 31, 2049 | |
| NCT06138639 | Recruiting | Phase 1/Phase 2 | A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | April 5, 2024 | January 15, 2030 |
| NCT05249361 | Recruiting | Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy | May 1, 2023 | October 1, 2025 | |
| NCT06402942 | Recruiting | N/A | Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy | June 1, 2024 | May 8, 2025 |
| NCT05280730 | Recruiting | Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy | February 2, 2022 | December 2024 | |
| NCT03057002 | Recruiting | UTSW HP [13-C] Pyruvate Injection in HCM | May 1, 2018 | November 8, 2024 | |
| NCT06270719 | Recruiting | An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy | February 7, 2024 | December 31, 2038 | |
| NCT05996003 | Recruiting | Phase 2 | NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) | February 22, 2024 | November 28, 2025 |
| NCT05409079 | Recruiting | N/A | Schulze Muscular Dystrophy Ability Clinical Study | May 26, 2022 | June 30, 2023 |
| NCT05412394 | Recruiting | Phase 4 | Once Weekly Infant Corticosteroid Trial for DMD | April 30, 2021 | December 30, 2026 |
| NCT06054971 | Recruiting | NSAA NON-Interventional Study Protocol | October 2, 2023 | May 2024 | |
| NCT06079736 | Recruiting | Phase 2 | A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment | January 8, 2024 | May 2027 |
| NCT06280209 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy | January 3, 2024 | December 2025 |
| NCT02972580 | Recruiting | Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD | June 2016 | December 2025 | |
| NCT03603288 | Terminated | Phase 3 | Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) | July 4, 2018 | November 25, 2020 |
| NCT03907072 | Terminated | Phase 2/Phase 3 | Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy | September 4, 2019 | January 9, 2020 |
| NCT03917719 | Terminated | Phase 3 | An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy | March 14, 2019 | October 26, 2020 |
| NCT01753804 | Terminated | A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy. | September 1, 2012 | October 1, 2016 | |
| NCT03985878 | Terminated | Phase 2 | A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) | June 26, 2019 | August 31, 2022 |
| NCT04371666 | Terminated | Phase 3 | Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD) | August 10, 2020 | August 17, 2023 |
| NCT01239758 | Terminated | Phase 2 | Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy | October 2010 | May 2011 |
| NCT04632940 | Terminated | Phase 3 | Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD | December 11, 2020 | December 12, 2023 |
| NCT01168908 | Terminated | Phase 2 | Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy | September 2010 | January 2014 |
| NCT04708314 | Terminated | Phase 4 | An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy | October 31, 2020 | May 13, 2021 |
| NCT01099761 | Terminated | Phase 2 | Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy | April 2010 | June 2011 |
| NCT02310763 | Terminated | Phase 2 | A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy | November 24, 2014 | November 23, 2018 |
| NCT02315339 | Terminated | European Home Mechanical Ventilation Registry | August 2014 | January 2019 | |
| NCT02329769 | Terminated | Phase 2 | Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD) | December 2014 | August 31, 2016 |
| NCT01009294 | Terminated | Phase 2 | Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD) | January 13, 2010 | March 23, 2010 |
| NCT00847379 | Terminated | Phase 2 | Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) | January 31, 2009 | May 24, 2010 |
| NCT01978366 | Terminated | Phase 2 | Open Label Extension Study of HT-100 in Patients With DMD | October 2013 | April 30, 2016 |
| NCT02525302 | Terminated | Phase 2 | HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02 | May 2015 | December 30, 2016 |
| NCT00839033 | Terminated | Phase 3 | Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders | June 2009 | December 2011 |
| NCT01957059 | Terminated | Phase 1/Phase 2 | A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD) | June 2013 | August 3, 2016 |
| NCT02606136 | Terminated | Phase 2 | Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) | January 4, 2016 | August 7, 2023 |
| NCT00308113 | Terminated | Phase 3 | CoQ10 and Prednisone in Non-Ambulatory DMD | April 2007 | November 2010 |
| NCT02858362 | Terminated | Phase 2 | Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD) | June 2016 | September 11, 2018 |
| NCT02907619 | Terminated | Phase 2 | An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy | October 13, 2016 | November 22, 2018 |
| NCT02958202 | Terminated | Phase 2 | Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD) | April 2016 | September 2016 |
| NCT01847573 | Terminated | Phase 1/Phase 2 | Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy | May 2013 | March 30, 2016 |
| NCT01826474 | Terminated | Phase 1/Phase 2 | Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy | January 2013 | August 31, 2016 |
| NCT00759876 | Terminated | Phase 2 | Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD) | August 13, 2008 | May 17, 2010 |
| NCT03531788 | Terminated | N/A | Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD | August 30, 2018 | December 31, 2020 |
| NCT03532542 | Terminated | Phase 3 | An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy | August 2, 2018 | July 26, 2023 |
| NCT03558958 | Terminated | Phase 2 | Safety and Efficacy of P-188 NF in DMD Patients | August 8, 2018 | September 1, 2021 |
| NCT01610440 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy | October 2011 | October 2013 |
| NCT00468832 | Unknown status | Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) | December 2005 | December 2019 | |
| NCT03067831 | Unknown status | Phase 1/Phase 2 | Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy | September 2015 | December 2021 |
| NCT05110885 | Unknown status | Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices | November 2021 | January 2022 | |
| NCT02484560 | Unknown status | Phase 1 | Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2 | June 2015 | December 2015 |
| NCT02436720 | Unknown status | Upper Limb Assessment in Duchenne Muscular Dystrophy | January 2013 | May 2015 | |
| NCT01834040 | Unknown status | Phase 1/Phase 2 | Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy | September 2014 | October 2016 |
| NCT01772043 | Unknown status | Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping | September 2012 | August 2016 | |
| NCT03372655 | Unknown status | Prognostic Factors Affecting Duchenne Muscular Dystrophy | January 1, 2018 | March 1, 2019 | |
| NCT05029232 | Unknown status | N/A | Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital | October 1, 2021 | August 1, 2023 |
| NCT04782440 | Unknown status | N/A | The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy | April 2021 | September 2021 |
| NCT02285673 | Unknown status | Phase 1/Phase 2 | Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy | November 2013 | November 2015 |
| NCT03443115 | Unknown status | Duchenne Muscular Dystrophy Heart Study | June 27, 2017 | March 15, 2020 | |
| NCT02196467 | Unknown status | Phase 1/Phase 2 | Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients | May 2014 | January 2024 |
| NCT03507530 | Unknown status | Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy | April 2018 | January 2019 | |
| NCT03513367 | Unknown status | The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM. | September 19, 2018 | September 19, 2019 | |
| NCT02109692 | Unknown status | N/A | Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies | May 19, 2014 | November 2019 |
| NCT04287582 | Unknown status | The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy | April 3, 2019 | April 1, 2020 | |
| NCT00606775 | Unknown status | Phase 4 | The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy | December 2007 | December 2012 |
| NCT03689660 | Unknown status | N/A | Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback | February 1, 2019 | October 1, 2023 |
| NCT01385917 | Unknown status | Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping | October 2011 | December 2018 | |
| NCT00819845 | Unknown status | Phase 4 | Ramipril Versus Carvedilol in Duchenne and Becker Patients | December 2008 | December 2016 |
| NCT03335384 | Withdrawn | N/A | Relationship Between PFTs and Pdi in DMD | May 1, 2018 | May 2018 |
| NCT03642145 | Withdrawn | Phase 3 | A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD) | October 31, 2018 | July 31, 2021 |
| NCT02241434 | Withdrawn | Phase 1 | Stem Cell Therapy in Duchenne Muscular Dystrophy | January 2009 | June 2016 |
| NCT02704325 | Withdrawn | Phase 1/Phase 2 | Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2 | April 2016 | February 2020 |
- Disase is a (Disease Ontology)
- DOID:9884
- Cross Reference ID (Disease Ontology)
- GARD:6291
- Cross Reference ID (Disease Ontology)
- MESH:D020388
- Cross Reference ID (Disease Ontology)
- MIM:310200
- Cross Reference ID (Disease Ontology)
- NCI:C75482
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155095006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0013264
- Exact Synonym (Disease Ontology)
- Muscular dystrophy, Duchenne
- OrphaNumber from OrphaNet (Orphanet)
- 98896
- MedGen concept unique identifier (MedGen Concept name)
- C0013264
- MedGen unique identifier (MedGen Concept name)
- 3925